Otsuka Holdings, sanofi-aventis deal

sanofi-aventis will end a 2006 deal with Otsuka’s Taiho Pharmaceutical Co. Ltd. subsidiary to develop and commercialize Otsuka’s S-1 to treat cancer. The decision comes after the dihydropyrimidine d...